Therapeutic Solutions International Reports Amplification of Cancer Specific Immune Responses Using Second Generation Tumor Endothelial Targeting Vaccine StemVacs-V iPSC

Author's Avatar
Jun 07, 2021

Company Demonstrates Existing Platform Can Synergize with Multiple Antigen Specific Tumor Immunotherapies

PR Newswire